Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 4
2014 5
2015 6
2016 7
2017 7
2018 8
2019 10
2020 11
2021 9
2022 9
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV.
Naeimi Kararoudi M, Likhite S, Elmas E, Yamamoto K, Schwartz M, Sorathia K, de Souza Fernandes Pereira M, Sezgin Y, Devine RD, Lyberger JM, Behbehani GK, Chakravarti N, Moriarity BS, Meyer K, Lee DA. Naeimi Kararoudi M, et al. Among authors: moriarity bs. Cell Rep Methods. 2022 Jun 13;2(6):100236. doi: 10.1016/j.crmeth.2022.100236. eCollection 2022 Jun 20. Cell Rep Methods. 2022. PMID: 35784645 Free PMC article.
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers.
Wong DP, Roy NK, Zhang K, Anukanth A, Asthana A, Shirkey-Son NJ, Dunmire S, Jones BJ, Lahr WS, Webber BR, Moriarity BS, Caimi P, Parameswaran R. Wong DP, et al. Among authors: moriarity bs. Nat Commun. 2022 Jan 11;13(1):217. doi: 10.1038/s41467-021-27853-w. Nat Commun. 2022. PMID: 35017485 Free PMC article.
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade.
Palmer DC, Webber BR, Patel Y, Johnson MJ, Kariya CM, Lahr WS, Parkhurst MR, Gartner JJ, Prickett TD, Lowery FJ, Kishton RJ, Gurusamy D, Franco Z, Vodnala SK, Diers MD, Wolf NK, Slipek NJ, McKenna DH, Sumstad D, Viney L, Henley T, Bürckstümmer T, Baker O, Hu Y, Yan C, Meerzaman D, Padhan K, Lo W, Malekzadeh P, Jia L, Deniger DC, Patel SJ, Robbins PF, McIvor RS, Choudhry M, Rosenberg SA, Moriarity BS, Restifo NP. Palmer DC, et al. Among authors: moriarity bs. Med. 2022 Oct 14;3(10):682-704.e8. doi: 10.1016/j.medj.2022.07.008. Epub 2022 Aug 24. Med. 2022. PMID: 36007524 Free PMC article.
Nonviral genome engineering of natural killer cells.
Robbins GM, Wang M, Pomeroy EJ, Moriarity BS. Robbins GM, et al. Among authors: moriarity bs. Stem Cell Res Ther. 2021 Jun 16;12(1):350. doi: 10.1186/s13287-021-02406-6. Stem Cell Res Ther. 2021. PMID: 34134774 Free PMC article. Review.
The Molecular Imaging of Natural Killer Cells.
Shapovalova M, Pyper SR, Moriarity BS, LeBeau AM. Shapovalova M, et al. Among authors: moriarity bs. Mol Imaging. 2018 Jan-Dec;17:1536012118794816. doi: 10.1177/1536012118794816. Mol Imaging. 2018. PMID: 30203710 Free PMC article. Review.
CRISPR/Cas9 library screening for drug target discovery.
Kurata M, Yamamoto K, Moriarity BS, Kitagawa M, Largaespada DA. Kurata M, et al. Among authors: moriarity bs. J Hum Genet. 2018 Feb;63(2):179-186. doi: 10.1038/s10038-017-0376-9. Epub 2017 Nov 20. J Hum Genet. 2018. PMID: 29158600 Review.
Coping with cancer genes altered by copy number.
Wolf NK, Largaespada DA, Moriarity BS. Wolf NK, et al. Among authors: moriarity bs. Oncotarget. 2015 Nov 3;6(34):35155-6. doi: 10.18632/oncotarget.6215. Oncotarget. 2015. PMID: 26577648 Free PMC article. No abstract available.
74 results